nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexobarbital—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0409	0.0444	CbGbCtD
Hexobarbital—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0398	0.0432	CbGbCtD
Hexobarbital—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0374	0.0406	CbGbCtD
Hexobarbital—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0367	0.0399	CbGbCtD
Hexobarbital—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0345	0.0375	CbGbCtD
Hexobarbital—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0345	0.0375	CbGbCtD
Hexobarbital—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0338	0.0367	CbGbCtD
Hexobarbital—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0338	0.0367	CbGbCtD
Hexobarbital—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0331	0.0359	CbGbCtD
Hexobarbital—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0312	0.0339	CbGbCtD
Hexobarbital—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0311	0.0338	CbGbCtD
Hexobarbital—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0311	0.0338	CbGbCtD
Hexobarbital—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0292	0.0317	CbGbCtD
Hexobarbital—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0284	0.0308	CbGbCtD
Hexobarbital—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0281	0.0305	CbGbCtD
Hexobarbital—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0281	0.0305	CbGbCtD
Hexobarbital—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0262	0.0284	CbGbCtD
Hexobarbital—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0257	0.0278	CbGbCtD
Hexobarbital—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0257	0.0278	CbGbCtD
Hexobarbital—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0246	0.0267	CbGbCtD
Hexobarbital—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0243	0.0264	CbGbCtD
Hexobarbital—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0237	0.0257	CbGbCtD
Hexobarbital—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0236	0.0256	CbGbCtD
Hexobarbital—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0213	0.0231	CbGbCtD
Hexobarbital—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0213	0.0231	CbGbCtD
Hexobarbital—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0204	0.0222	CbGbCtD
Hexobarbital—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0192	0.0209	CbGbCtD
Hexobarbital—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0181	0.0196	CbGbCtD
Hexobarbital—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0181	0.0196	CbGbCtD
Hexobarbital—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0164	0.0178	CbGbCtD
Hexobarbital—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0164	0.0178	CbGbCtD
Hexobarbital—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0141	0.0153	CbGbCtD
Hexobarbital—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0137	0.0149	CbGbCtD
Hexobarbital—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0124	0.0135	CbGbCtD
Hexobarbital—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0124	0.0135	CbGbCtD
Hexobarbital—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0119	0.0129	CbGbCtD
Hexobarbital—GRIK2—nerve—acquired immunodeficiency syndrome	0.0047	0.06	CbGeAlD
Hexobarbital—CHRNA4—nerve—acquired immunodeficiency syndrome	0.00378	0.0482	CbGeAlD
Hexobarbital—GRIK2—retina—acquired immunodeficiency syndrome	0.00195	0.0248	CbGeAlD
Hexobarbital—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00186	0.0237	CbGeAlD
Hexobarbital—CHRNA7—retina—acquired immunodeficiency syndrome	0.00159	0.0202	CbGeAlD
Hexobarbital—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00152	0.0194	CbGeAlD
Hexobarbital—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00148	0.0189	CbGeAlD
Hexobarbital—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00144	0.0184	CbGeAlD
Hexobarbital—CHRNA7—skin of body—acquired immunodeficiency syndrome	0.00139	0.0178	CbGeAlD
Hexobarbital—GRIA2—spinal cord—acquired immunodeficiency syndrome	0.00139	0.0177	CbGeAlD
Hexobarbital—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.00137	0.0174	CbGeAlD
Hexobarbital—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00132	0.0168	CbGeAlD
Hexobarbital—CHRFAM7A—blood—acquired immunodeficiency syndrome	0.00131	0.0168	CbGeAlD
Hexobarbital—GRIK2—spinal cord—acquired immunodeficiency syndrome	0.00126	0.016	CbGeAlD
Hexobarbital—GRIA2—nervous system—acquired immunodeficiency syndrome	0.00117	0.0149	CbGeAlD
Hexobarbital—GABRA6—nervous system—acquired immunodeficiency syndrome	0.00113	0.0144	CbGeAlD
Hexobarbital—GRIA2—central nervous system—acquired immunodeficiency syndrome	0.00113	0.0144	CbGeAlD
Hexobarbital—CHRNA7—digestive system—acquired immunodeficiency syndrome	0.00111	0.0142	CbGeAlD
Hexobarbital—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.0011	0.014	CbGeAlD
Hexobarbital—CHRNA4—digestive system—acquired immunodeficiency syndrome	0.0011	0.014	CbGeAlD
Hexobarbital—GABRA5—nervous system—acquired immunodeficiency syndrome	0.0011	0.014	CbGeAlD
Hexobarbital—GABRA6—central nervous system—acquired immunodeficiency syndrome	0.00109	0.0139	CbGeAlD
Hexobarbital—CHRFAM7A—nervous system—acquired immunodeficiency syndrome	0.00107	0.0136	CbGeAlD
Hexobarbital—CHRNA7—blood—acquired immunodeficiency syndrome	0.00106	0.0135	CbGeAlD
Hexobarbital—GRIK2—nervous system—acquired immunodeficiency syndrome	0.00106	0.0135	CbGeAlD
Hexobarbital—GABRA5—central nervous system—acquired immunodeficiency syndrome	0.00106	0.0135	CbGeAlD
Hexobarbital—CHRFAM7A—central nervous system—acquired immunodeficiency syndrome	0.00103	0.0131	CbGeAlD
Hexobarbital—GABRA3—nervous system—acquired immunodeficiency syndrome	0.00102	0.013	CbGeAlD
Hexobarbital—GRIK2—central nervous system—acquired immunodeficiency syndrome	0.00102	0.013	CbGeAlD
Hexobarbital—CHRNA4—spinal cord—acquired immunodeficiency syndrome	0.00101	0.0129	CbGeAlD
Hexobarbital—GABRA4—nervous system—acquired immunodeficiency syndrome	0.000995	0.0127	CbGeAlD
Hexobarbital—GABRA3—central nervous system—acquired immunodeficiency syndrome	0.000983	0.0125	CbGeAlD
Hexobarbital—GABRA4—central nervous system—acquired immunodeficiency syndrome	0.000958	0.0122	CbGeAlD
Hexobarbital—CHRNA4—lung—acquired immunodeficiency syndrome	0.000918	0.0117	CbGeAlD
Hexobarbital—GRIA2—brain—acquired immunodeficiency syndrome	0.000895	0.0114	CbGeAlD
Hexobarbital—GABRA1—spinal cord—acquired immunodeficiency syndrome	0.000873	0.0111	CbGeAlD
Hexobarbital—GABRA2—vagina—acquired immunodeficiency syndrome	0.000869	0.0111	CbGeAlD
Hexobarbital—GABRA6—brain—acquired immunodeficiency syndrome	0.000864	0.011	CbGeAlD
Hexobarbital—CHRNA7—nervous system—acquired immunodeficiency syndrome	0.000861	0.011	CbGeAlD
Hexobarbital—CHRNA4—nervous system—acquired immunodeficiency syndrome	0.00085	0.0108	CbGeAlD
Hexobarbital—GABRA5—brain—acquired immunodeficiency syndrome	0.000839	0.0107	CbGeAlD
Hexobarbital—CHRNA7—central nervous system—acquired immunodeficiency syndrome	0.000829	0.0106	CbGeAlD
Hexobarbital—CHRNA4—central nervous system—acquired immunodeficiency syndrome	0.000818	0.0104	CbGeAlD
Hexobarbital—CHRFAM7A—brain—acquired immunodeficiency syndrome	0.000815	0.0104	CbGeAlD
Hexobarbital—GRIK2—brain—acquired immunodeficiency syndrome	0.000808	0.0103	CbGeAlD
Hexobarbital—GABRA3—brain—acquired immunodeficiency syndrome	0.000781	0.00996	CbGeAlD
Hexobarbital—GABRA4—brain—acquired immunodeficiency syndrome	0.000761	0.00971	CbGeAlD
Hexobarbital—GABRA2—nervous system—acquired immunodeficiency syndrome	0.000761	0.0097	CbGeAlD
Hexobarbital—GABRA1—nervous system—acquired immunodeficiency syndrome	0.000735	0.00938	CbGeAlD
Hexobarbital—GABRA2—central nervous system—acquired immunodeficiency syndrome	0.000732	0.00934	CbGeAlD
Hexobarbital—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000716	0.00913	CbGeAlD
Hexobarbital—GABRA1—central nervous system—acquired immunodeficiency syndrome	0.000708	0.00903	CbGeAlD
Hexobarbital—CYP2C19—blood—acquired immunodeficiency syndrome	0.000682	0.0087	CbGeAlD
Hexobarbital—CHRNA7—brain—acquired immunodeficiency syndrome	0.000658	0.0084	CbGeAlD
Hexobarbital—CHRNA4—brain—acquired immunodeficiency syndrome	0.00065	0.00829	CbGeAlD
Hexobarbital—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000633	0.00808	CbGeAlD
Hexobarbital—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000632	0.00806	CbGeAlD
Hexobarbital—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000585	0.00746	CbGeAlD
Hexobarbital—GABRA2—brain—acquired immunodeficiency syndrome	0.000581	0.00742	CbGeAlD
Hexobarbital—GABRA1—brain—acquired immunodeficiency syndrome	0.000562	0.00717	CbGeAlD
Hexobarbital—GABRA2—lymph node—acquired immunodeficiency syndrome	0.000562	0.00717	CbGeAlD
Hexobarbital—CYP1A2—blood—acquired immunodeficiency syndrome	0.000557	0.00711	CbGeAlD
Hexobarbital—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000555	0.00708	CbGeAlD
Hexobarbital—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000532	0.00679	CbGeAlD
Hexobarbital—CYP2C9—blood—acquired immunodeficiency syndrome	0.000529	0.00675	CbGeAlD
Hexobarbital—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000526	0.00671	CbGeAlD
Hexobarbital—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000507	0.00646	CbGeAlD
Hexobarbital—CYP2E1—blood—acquired immunodeficiency syndrome	0.000501	0.00639	CbGeAlD
Hexobarbital—CYP1A2—lung—acquired immunodeficiency syndrome	0.000488	0.00623	CbGeAlD
Hexobarbital—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000483	0.00616	CbGeAlD
Hexobarbital—PTGS1—blood—acquired immunodeficiency syndrome	0.000483	0.00616	CbGeAlD
Hexobarbital—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000465	0.00593	CbGeAlD
Hexobarbital—PTGS1—vagina—acquired immunodeficiency syndrome	0.000447	0.00571	CbGeAlD
Hexobarbital—CYP2E1—lung—acquired immunodeficiency syndrome	0.000439	0.0056	CbGeAlD
Hexobarbital—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000423	0.0054	CbGeAlD
Hexobarbital—PTGS1—lung—acquired immunodeficiency syndrome	0.000423	0.0054	CbGeAlD
Hexobarbital—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000407	0.00519	CbGeAlD
Hexobarbital—CYP3A4—blood—acquired immunodeficiency syndrome	0.000403	0.00514	CbGeAlD
Hexobarbital—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000392	0.005	CbGeAlD
Hexobarbital—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000392	0.005	CbGeAlD
Hexobarbital—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000377	0.00481	CbGeAlD
Hexobarbital—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000327	0.00418	CbGeAlD
Hexobarbital—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000315	0.00402	CbGeAlD
Hexobarbital—CYP2E1—brain—acquired immunodeficiency syndrome	0.000311	0.00397	CbGeAlD
Hexobarbital—PTGS1—brain—acquired immunodeficiency syndrome	0.0003	0.00382	CbGeAlD
Hexobarbital—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000289	0.00369	CbGeAlD
